Impact BioMedical Overview

Impact BioMedical Operating Income

Operating Income for IBO.

Quarterly Operating Income

$-2289000.00

↑ 126.63% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-1247000.00

↓ 95.7% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin